Is there a definite relationship between placental mTOR signaling and fetal growth?
Is there a definite relationship between placental mTOR signaling and fetal growth?
复制标题
DOI：
10.1093/biolre/ioaa070
复制
发表时间：
2020
期刊：
影响因子：
--
通讯作者：
Xiaohong Wang
中科院分区：
文献类型：
--
作者：
Jie Dong;Na Shin;Shuqiang Chen;Jun Lei;Irina Burd;Xiaohong Wang
Fetal growth restriction and overgrowth are common obstetrical complications that result in adverse perinatal outcomes and long-term health risks later in life, including neurodevelopmental dysfunction and adult metabolic syndrome. The placenta plays a critical role in the nutrition transfer from mother to fetus and even exerts adaptive mechanism when the fetus is under poor developmental conditions. The mammalian/mechanistic target of rapamycin (mTOR) signaling serves as a critical hub of cell growth, survival, and metabolism in response to nutrients, growth factors, energy, and stress signals. Placental mTOR signaling regulates placental function, including oxygen and nutrient transport. Therefore, placental mTOR signaling is hypothesized to have a positive relationship with fetal growth. In this review, we summarize that most studies support the current evidence that there is connection between placental mTOR signaling and abnormal fetal growth; however, but more studies should be performed following a vigorous and unanimous method for assessment to determine placental mTOR activity.
